 |
|
Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
Moon Jin Kim, Sung Min Kim, Hyun Ae Jung, Jung Yong Hong, Won Jin Chang, Moon Ki Choi, Hye Sook Kim, Jong-Mu Sun, Keunchil Park, Myung-Ju Ahn
Korean J Intern Med. 2019;34(5):1107-1115. Published online 2018 Jun 20 DOI: https://doi.org/10.3904/kjim.2017.234
|
|
Citations to this article as recorded by
 A circadian rhythm-related lncRNA signature correlates with prognosis and tumor immune microenvironment in head and neck squamous cell carcinoma
Hongyu Zheng, Qiuyue Li, Kai Yang
Discover Oncology.2024;[Epub] CrossRef Cisplatin/docetaxel
Reactions Weekly.2019; 1779(1): 69. CrossRef
|